Do you know the difference between a rep who can't and a rep who won't?
It sounds like a simple question. Most sales leaders will tell you they do. But push a little harder. Ask them to name a rep on their current team and say which category that person is in. And the answer gets complicated fast. There's usually a pause. A qualifier. It depends on the day. Or the honest version: I've been coaching them for eight months and I'm still not sure.
That uncertainty is expensive in any organization. In yours, it may be existential.
If you lead a sales team in specialty pharma, rare disease, or a commercial-stage start-up, you already know the math is different. You don't have twenty reps covering a broad primary care market. You have six, or ten, maybe fifteen, each one carrying a territory that took years to build, calling on a physician universe that your entire commercial strategy depends on. There is no depth chart. There is no one to absorb a performance problem while you figure it out.
One rep in a persistent plateau isn't a personnel issue. It's a material business risk.
And yet the tools most commercial leaders reach for, the coaching frameworks, the performance management systems, the development structures, were built for large organizations with HR departments, training teams, and enough headcount to run a PIP without disrupting the entire salesforce culture. They feel like they were designed for someone else's problem. Because they were.
So most small-team commercial leaders do one of two things. They over-coach, spending disproportionate time with struggling reps, hoping effort alone produces improvement. Or they under-act, tolerating performance that they'd move on quickly in a larger organization, because the cost of a bad separation feels too high and the path forward feels unclear.
Neither approach serves the team. And the team knows it.
Here's what actually separates the commercial leaders who build high-performing small teams from those who don't: they make the diagnosis first.
Before the next coaching conversation. Before the next field ride. Before the next performance review that produces a plan nobody follows.
They ask: Does this person have a skill problem or a will problem?
A skill problem means the rep doesn't yet execute the behavior consistently, not because they won't, but because they haven't been coached to a specific, defined standard with enough continuity to make it stick. That's a coaching situation. The right response is a focused development plan, a clear target, and a manager who stays with it long enough to see it through.
A will problem means the rep knows what's expected, has demonstrated the capability, and is making a choice. That's a different conversation entirely, one that requires directness, named consequences, and a timeline. Not another round of coaching that neither party believes in.
The cost of confusing the two isn't just wasted coaching time. It's the message it sends to the rest of the team, the ones who are executing, who are watching how you handle the ones who aren't.
Small specialty and rare disease teams don't need less structure than large organizations. They need more precisely because there's no margin for prolonged ambiguity, repeated misdiagnosis, or performance problems that drift for quarters without resolution.
The question isn't whether your team needs a coaching and development framework. It's whether the one you're using was built for a team your size, in a market like yours, with stakes this high.
If you're not sure, that's worth a conversation.
Recognizing the difference between a skill problem and a will problem is the first step. The harder part is making sure every manager on your team diagnoses and coaches those situations the same way.
In small specialty and rare disease organizations, inconsistent coaching quickly becomes visible. One manager tolerates a plateau for too long. Another over-coaches without addressing accountability. Meanwhile the rest of the team is watching how performance issues are handled and adjusting their expectations accordingly.
High-performing organizations reduce that ambiguity by grounding coaching in clear standards of execution and observable behaviors. Instead of relying on instinct or individual coaching styles, leaders use structured approaches that make expectations explicit, help managers diagnose performance issues more accurately, and reinforce the behaviors that drive commercial results.
Echelon’s Evidence-Based Coaching (EBC) was built from thousands of real coaching conversations inside life sciences organizations. Implemented through En Fuego Leadership, the approach equips commercial leaders with practical frameworks that strengthen execution discipline, improve coaching consistency across regions, and drive measurable behavior change in the field.
If leadership consistency and commercial execution matter to your organization, reach out for a consultation with En Fuego.